96935 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Apoptosis related proteins
METHODS OF PRODUCING POLYPEPTIDES USING A CELL LINE RESISTANT TO APOPTOSIS
#2DRUG RESISTANT IMMUNE CELLS
#3CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#4Compositions And Methods For Enhancing Adoptive T Cell Therapeutics
#5GENETICALLY ENGINEERED MICE MODELS FOR MULTIPLE MYELOMA
#6APOPTOSIS RESISTANT CELL LINES
#7METHODS AND COMPOSITIONS FOR SELECTIVELY ELIMINATING CELLS OF INTEREST
#8INDUCIBLE CASPASES AND METHODS FOR USE
#9PEPTIDE THERAPEUTICS FOR THE TREATMENT OF CANCER AND USES THEREOF
#10CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#11AMELIORATION AND TREATMENT OF INFARCTION DAMAGE
#12P97-BASE PROTAC ANTIBODY CONJUGATES AND METHODS OF USE
#13TRUNCATED DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR DECREASING VIABILITY OF NEOPLASTIC CELLS
#14BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss
#15Nucleic Acids, Methods and Kits for the Diagnosis of DYT6 Primary Torsion Dystonia
#16POLYMER MOLECULE, MONOMERIC STRUCTURE AND POLYMERIC STRUCTURE COMPRISING SAME
#17METHODS AND COMPOSITIONS RELATING TO THE TREATMENT OF TUMORS
#18COMPOSITIONS TARGETING APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN WITH CASPASE ACTIVATION AND RECRUITMENT DOMAIN (ASC) AND METHODS OF USE
#19ESTABLISHMENT OF ERYTHROID PRECURSOR CELL LINE CAPABLE OF CONDITIONAL MATURATION USING GENE OVEREXPRESSION
#20PRO-APOPTOTIC CONSTRUCT AND USE THEREOF
#21BAG3 COMPOSITIONS AND METHODS
#22INFLAMMASOME INHIBITION
#23CELLS EXPRESSING FAS LIGAND AND CFLIP POLYPEPTIDES AND USES THEREOF
#24METHODS OF TREATING CANCER HAVING AN ACTIVE WNT/BETA-CATENIN PATHWAY
#25ACTIVATION OF SURVIVIN-SPECIFIC IMMUNE RESPONSES USING DENDRITIC CELL DERIVED EXOSOMES
#26MODULATION OF BCL-2 TO ENHANCE CHIMERIC ANTIGEN RECEPTOR CANCER IMMUNOTHERAPY EFFICACY
#27APPLICATION OF APOPTOSIS INHIBITOR 5 (API5) FOR EPITHELIAL RESTITUTION
#28IMMUNE CELLS ENGINEERED TO PROMOTE THANOTRANSMISSION AND USES THEREOF
#29POLYPEPTIDE BAX/NPM INHIBITORS
#30NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE
#31CHIMERIC ANTIGEN RECEPTORS, COMPOSITIONS, AND METHODS
#32COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS
#33COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS
#34Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (ASC) and methods of use
#35Compositions and methods for enhancing adoptive T cell therapeutics
#36PHOTOACTIVATABLE GASDERMIN PROTEINS
#37IL-13RALPHA2 TARGETED IMMUNOTOXINS AND METHODS OF USE
#38AMELIORATION AND TREATMENT OF INFARCTION DAMAGE
#39HYPOIMMUNOGENIC CELLS COMPRISING ENGINEERED HLA-E OR HLA-G
#40NOVEL SCREENING SYSTEM FOR DRUG TARGET ANTAGONIST BASED ON CELL LIFE/DEATH PHENOTYPE
#41MODIFIED CELLS FOR THE PRODUCTION OF A RECOMBINANT PRODUCT OF INTEREST
#42NUCLEIC ACID MOLECULES ENCODING TRIF AND ADDITIONAL POLYPEPTIDES AND THEIR USE IN TREATING CANCER
#43HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
#44COMPOSITIONS AND METHODS FOR ENHANCING ADOPTIVE T CELL THERAPEUTICS
#45INCREASED PACKAGING EFFICIENCY OF VECTOR FOR CARDIAC GENE THERAPY
#46Cancer Stem Cell Targeted Cancer Vaccines
#47SELECTIVE MCL-1 BINDING PEPTIDES
#48VACCINE FORMULATION COMPRISING RECOMBINANT OVERLAPPING PEPTIDES AND NATIVE PROTEINS
#49CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#50INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF
#51HIDDEN ANTIBIOTICS IN THE HUMAN PROTEOME
#52MODIFIED IMMUNE EFFECTOR CELL AND USE THEREOF
#53PD-1 DECOY VARIANTS FOR IMMUNOTHERAPY
#54ANTI-APOPTOTIC VECTOR AND METHOD OF USING THE SAME
#55METHODS OF TREATING NEURONAL DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR miR-142 AND COMPOSITIONS THEREOF
#56INDUCIBLE CASPASES AND METHODS FOR USE
#57GENE FUSIONS FOR CONTROL OF GENETICALLY MODIFIED CELLS
#58METHODS FOR GENERATING PRIMARY IMMUNE CELLS
#59SMAC/Diablo inhibitors useful for treating cancer
#60TREATMENT OF NEURODEGENERATIVE PROTEINOPATHIES USING FAS APOPTOSIS INHIBITORY MOLECULE (FAIM) OR A FRAGMENT AND/OR A MIMETIC THEREOF
#61COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS
#62METHOD FOR IDENTIFYING COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER
#63SERINE PROTEASE MOLECULES AND THERAPIES
#64STRUCTURALLY-STABILIZED AND HDMX-SELECTIVE P53 PEPTIDES AND USES THEREOF
#65CHIMERIC POLYPEPTIDE FOR REGULATING IMMUNE CELLS
#66Compositions and methods for delivery of nucleic acids to cells
#67Compositions and methods for delivery of nucleic acids to cells
#68BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss
#69Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia
#70Compositions and methods for delivery of nucleic acids to cells
#71Inducible caspases and methods for use
#72ENGINEERED HIGH-AFFINITY HUMAN T CELL RECEPTORS
#73ASC SPECKS IN CANCER IMMUNOTHERAPY
#74Interleukin-4 Receptor-Binding Fusion Proteins and Uses Thereof
#75Engineered Peptide and Peptide Mimetic Compositions and Methods
#76Method of treating diseases of the visual system
#77MULTIMERIC PROTEIN DOMAINS FOR MULTIFUNCTIONALITY AND ENHANCED SECRETION OF THERAPEUTIC PROTEINS
#78REDIRECTING DEATH-INDUCING SIGNAL COMPLEX (DISC) BY MODIFYING DEATH RECEPTOR AGONIST TO INDUCE CELL DEATH FOR CANCER TREATMENT
#79BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF
#80ANTIBODIES AGAINST PD-1 AND METHODS OF USE THEREOF
#81BNIP3 PEPTIDES FOR TREATMENT OF REPERFUSION INJURY
#82LOCKR-MEDIATED RECRUITMENT OF CAR T CELLS
#83MODULATING SURVIVAL OF THERAPEUTIC CELLS AND METHODS, CELLS AND NUCLEIC ACIDS RELATED THERETO
#84TRANSPOSON-BASED MODIFICATIONS OF IMMUNE CELLS
#85METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
#86CONDITIONALLY IMMORTALIZED LONG-TERM STEM CELLS AND METHODS OF MAKING AND USING SUCH CELLS
#87TETRAMERIC PROTEIN SCAFFOLDS AS NANO-CARRIERS OF THERAPEUTIC PEPTIDES FOR TREATING CANCER AND OTHER DISEASES
#88MESOTHELIN CARS AND USES THEREOF
#89BH4 Stabilized Peptides And Uses Thereof
#90Methods of Regulating Oxidoreductase Activity for Treatment of Inflammation and Age-Related Disorders
#91INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF
#92APOPTOSIS RESISTANT CELL LINES
#93SELECTIVE MCL-1 BINDING PEPTIDES
#94PEPTIDE THERAPEUTICS FOR THE TREATMENT OF CANCER AND USES THEREOF
#95METHODS OF PRODUCING POLYPEPTIDES USING A CELL LINE RESISTANT TO APOPTOSIS
#96METHOD OF RESPONSE PREDICTION FOR BCL2 FAMILY PROTEIN TARGETING DRUG
#97TWEAK-receptor agonists for use in combination with immunotherapy of a cancer
#98PROTEIN-BASED MICELLES FOR THE DELIVERY OF HYDROPHOBIC ACTIVE COMPOUNDS
#99SMAC/Diablo inhibitors useful for treating cancer
#100Interleukin-2 fusion proteins and uses thereof
#101METHOD OF RESPONSE PREDICTION FOR BCL2 FAMILY PROTEIN TARGETING DRUG
#102ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT
#103Autophagy inhibitors
#104Purification and identification of a protein complex containing b-cell lymphoma protein (BCL10)
#105TRPV3 agonists for the treatment of skin conditions
#106Method of treating disorders associated with chronic inflammation
#107Cancer stem cell targeted cancer vaccines
#108Analogues of VDAC1-derived peptides
#109High affinity PD-1 agents and methods of use
#110Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss
#111Methods of treating sarcopenia
#112Method for producing chimeric animal
#113Serine protease molecules and therapies
#114CONDITIONALLY IMMORTALIZED LONG-TERM STEM CELLS AND METHODS OF MAKING AND USING SUCH CELLS
#115Chimeric antigen receptors, compositions, and methods
#116Retroviral vectors
#117PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
#118Method of treating coronavirus
#119Method of treating viral infections
#120Method of regulating tumor necrosis factor-alpha (TNF-α) for treating cancers, autoimmune disorders, and other disorders associated with chronic inflammation
#121ARTIFICIAL ANTIGEN PRESENTING CELLS INCLUDING HLA-E AND HLA-G MOLECULES AND METHODS OF USE
#122Methods of treating cancer having an active Wnt/β-catenin pathway
#123Method of treating multiple sclerosis
#124Powerful MHC-class II peptides derived from survivin
#125Methods of reversing normal aging process and extending lifespan
#126ANTIBODIES TO NON-FUNCTIONAL P2X7 RECEPTOR
#127Pharmaceutical salts of isomyosmine and pharmaceutical compositions containing same
#128Non-human animals having a humanized programmed cell death 1 gene
#129Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer agents
#130Serine protease molecules and therapies
#131Analogues of VDAC1-derived peptides
#132p53-BAD fusion proteins
#133Methods and compositions relating to the treatment of tumors
#134Engineered potent cytotoxic stapled BH3 peptides
#135Serine protease molecules and therapies
#136Rewiring aberrant cancer signaling to a therapeutic effector response with a synthetic two-component system
#137Site-selective modification of polysaccharides and applications thereof
#138METHODS AND COMPOSITIONS FOR GENE EDITING IN STEM CELLS
#139Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia
#140Inducible caspases and methods for use
#141Selective Bfl-1 peptides
#142Profiling peptides and methods for sensitivity profiling
#143Method for treating Alzheimer's disease and method for downregulating protein aggregation in brain
#144Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
#145MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF
#146Interleukin-4 receptor-binding fusion proteins and uses thereof
#147Interleukin-4 receptor-binding fusion proteins and uses thereof
#148BH4 stabilized peptides and uses thereof
#149SELECTIVE MCL-1 BINDING PEPTIDES
#150ENGINEERED HIGH-AFFINITY HUMAN T CELL RECEPTORS
#151REWIRING ABERRANT CANCER SIGNALING TO A THERAPEUTIC EFFECTOR RESPONSE WITH A SYNTHETIC TWO-COMPONENT SYSTEM
#152Conditionally immortalized long-term stem cells and methods of making and using such cells
#153PROTOCOL FOR INCREASING LIFE EXPECTANCY IN A TEST SUBJECT
#154Multimodal trail molecules expressed in T cells
#155Peptides binding to Bfl-1
#156Method for producing chimeric animal
#157ANTI-TNF INDUCED APOPTOSIS (ATIA) DIAGNOSTIC MARKERS AND THERAPIES
#158Chimeric antigen receptor-modified immune effector cell carrying PD-L1 blocking agent
#159Polypeptide
#160Listeria-Based Immunogenic Compositions And Methods Of Use Thereof in Cancer Prevention And Treatment
#161Profiling peptides and methods for sensitivity profiling
#162BAG3 COMPOSITIONS AND METHODS
#163BH3 peptides and methods of use thereof
#164NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE
#165Serine protease molecules and therapies
#166COMPOSITIONS AND METHODS FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS
#167Profiling peptides and methods for sensitivity profiling
#168Analogues of VDAC1-derived peptides
#169Cell Lines
#170Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
#171BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF
#172TRPV3 agonists for the treatment of skin conditions
#173Methods of treating diabetes
#17413+/17+ BIN1 expression as a marker of cardiac disorders
#175Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor
#176Methods of altering programmed cell death and extending cell life
#177Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway
#178Anti-senescence compounds and uses thereof
#179Synthetic promoters for high throughput screening and gene modulation
#180Chimeric antigen receptors, compositions, and methods
#181Virus Vectors Expressing Multiple Epitopes of Tumor Associated Antigens For Inducing Antitumor Immunity
#182METHODS AND COMPOSITIONS FOR SELECTIVELY ELIMINATING CELLS OF INTEREST
#183Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor
#184MHC-I restricted epitopes containing non-natural amino acid residues
#185PEPTIDOMIMETIC MACROCYCLES
#186Compositions comprising GRIM-19 therapeutics and methods of use
#187Bis-sulfhydryl macrocyclization systems
#188Methods and compositions for diagnosis and treatment of cancer
#189COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEUROLOGICAL DISEASE
#190High affinity PD-1 agents and methods of use
#191Calbindin and BH3 domain chimeric proteins and methods for use
#192DR6 Receptor Mediates the Leukemia Differentiation Activity of Angiocidin: A Potent Anti-Tumor Peptide
#193Methods for treating cancer with EGFR nanobodies linked to DR5 binding moieties
#194Site-selective modification of polysaccharides and applications thereof
#195Method of treating BCL-2 over-expressing disorders using arts containing a BH3-like domain
#196Stitched polypeptides
#197Methods and pharmaceutical compositions for the treatment of cancer
#198Membrane-anchoring and apoptosis-inducing fusion protein comprising a fragment of TRAIL and CD40L and encoding polynucleotides
#199Composition comprising branched multipeptide vaccine and vaccine comprising the same
#200Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor
#201Cell-surface marker of early MSC aging
#202PRO-APOPTOTIC RAS AND RAF PEPTIDES
#203Vectors and methods for the efficient generation of integration/transgene-free induced pluripotent stem cells from peripheral blood cells
#204STABILIZED ALPHA HELICAL PEPTIDES AND USES THEREOF
#205Bcl-2-like protein 11 SRM/MRM assay
#206Engineered potent cytotoxic stapled BH3 peptides
#207Polypeptides to inhibit epstein barr viral protein BHRF1 and B cell lymphoma family proteins
#208IAP antagonists
#209Expansion of adult stem cells in vitro
#210Biodegradable matrix comprising stem cells that express soluble TRAIL
#211Engineered high-affinity human t cell receptors
#212Engineered high-affinity human T cell receptors
#213Survivin-Directed Cancer Vaccine Therapy
#214COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH y-HERPESVIRUSES
#215Cell-penetrating peptides
#216Interleukin-4 receptor-binding fusion proteins and uses thereof
#217Interleukin-2 fusion proteins and uses thereof
#218Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia
#219Interleukin-4 receptor-binding fusion proteins and uses thereof
#220BH3 peptides and methods of use thereof
#221Uses of partial peptides of survivin and variations thereof
#222METHOD AND COMPOSITION FOR GENERATING PROGRAMMED CELL DEATH RESISTANT ALGAL CELLS
#223Partial region polypeptide of REIC/Dkk-3 protein
#224Short peptides derived from VDAC1, compositions and methods of use thereof
#225COMPOSITION AND VACCINE FOR TREATING LUNG CANCER
#226Compositions and methods for targeted endometriosis treatment
#227Molecules of the card-related protein family and uses thereof
#228Method for producing antibody using “naked” expression vector expressing type II transmembrane fusion protein
#229Interference peptides and use thereof
#230MELK epitope peptides and vaccines containing the same
#231Means and methods for producing high affinity antibodies
#232PEPTIDOMIMETIC MACROCYCLES
#233Bis-sulfhydryl macrocyclization systems
#234METHOD FOR PRODUCING CHIMERIC ANIMAL
#235Maternally induced sterility in animals
#236BH4 stabilized peptides and uses thereof
#237CHEMOTHERAPEUTIC AGENTS COMPRISING A CHIMERIC GENE, METHODS OF PRODUCING THE SAME, AND METHODS OF TREATING CANCEROUS CELLS USING THE SAME
#238MHC-I restricted epitopes containing non-natural amino acid residues
#239Non-human animals having a humanized programmed cell death 1 gene
#240Autophagy-inducing peptide analogs
#241Dual-targeted therapeutic peptide for nasopharyngeal carcinoma, nanoparticles carrying same and uses thereof
#242Antibodies to non-functional P2X7 receptor
#243Polypeptides capable of cellular internalization
#244Therapeutic agent for cancer
#245Methods and compositions for specific modulation of MCL-1
#246Conditionally immortalized long-term stem cells and methods of making and using such cells
#247BLID; protein domain for interaction with the Bcl-2 family of proteins
#248Multifunctional nanobodies for treating cancer
#249Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
#250Method for antigen delivery
#251Cancer stem cell targeted cancer vaccines
#252Immunomodulating cyclic compounds
#253BLID; a novel protein domain for interaction with the Bcl-2 family of proteins. Applications in oncology
#254Prophylactic or therapeutic agent for hepatic diseases
#255Methods of treating cancer having an active Wnt/β-catenin pathway
#256CD4+ T survivin epitopes and uses thereof
#257Engineered potent cytotoxic stapled BH3 peptides
#258Compositions and methods of treating cancer
#259Anti-tumor adjuvant therapy
#260ANTAGONISTS OF Bcl-2 AND USES THEREOF IN INDUCTION OF APOPTOSIS
#261Serine protease molecules and therapies
#262Cell-penetrating peptides
#263Compositions and methods for purifying Bax
#264Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof
#265Kinase inhibitors and uses thereof
#266Serine protease molecules and therapies
#267Bin1 as a prognostic marker in cardiovascular disease
#268Stabilized alpha helical peptides and uses thereof
#269PTD-SMAD7 therapeutics
#270PEPTIDES AND METHODS FOR INDUCING CELL DEATH
#271Compositions And Methods For Modulating Apoptosis
#272Melk epitope peptides and vaccines containing the same
#273Serine protease molecules and therapies
#274Bis-sulfhydryl macrocyclization systems
#275Annexin V variant and its preparation and application
#276Powerful MHC-class II peptides derived from survivin
#277Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins
#278Treatment and bioluminescent visualization using multimodal TRAIL molecules
#279Autophagy-inducing peptide
#280PEPTIDES AND METHODS FOR INDUCING CELL DEATH
#281Cross-linked peptides and proteins, methods of making same, and uses thereof
#282MHC-I restricted epitopes containing non-natural amino acid residues
#283Means and methods for producing high affinity antibodies
#284BLID; a novel protein domain for interaction with the Bcl-2 family of proteins
#285Powerful MHC-class II peptides derived from survivin
#286HIGHLY POTENT PEPTIDES TO CONTROL CANCER AND NEURODEGENERATIVE DISEASES
#287BCL-2-like protein 11 SRM/MRM assay
#288Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide and nucleic acids encoding the same
#289Inhibitors of apoptosis and uses thereof
#290Anticancer fusion protein comprising trail and a growth factor receptor inhibitor
#291Oxidative stress responsive apoptosis inducing protein eIF5A
#292Direct administration of REIC/Dkk-3 to mesothelioma
#293Inhibitors of Bcl-2
#294Puf-A and related compounds for treatment of retinopathies and sight-threatening ophthalmologic disorders
#295BNIP3 ISOFORMS AND METHODS OF USE
#296Kinase inhibitors and uses thereof
#297Anticancer fusion protein comprising trail
#298ASPP2 splicing variant
#299Survivin-derived peptides and uses thereof
#300METHOD AND COMPOSITION FOR GENERATING PROGRAMMED CELL DEATH RESISTANT ALGAL CELLS